|
1
|
Ng SS, Gao Y, Chau DH, et al: A novel
glioblastoma cancer gene therapy using AAV-mediated long-term
expression of human TERT C-terminal polypeptide. Cancer Gene Ther.
14:561–572. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lin ZX, Yang LJ, Huang Q, et al:
Inhibition of tumor-induced edema by antisense VEGF is mediated by
suppressive vesiculo-vacuolar organelles (VVO) formation. Cancer
Sci. 99:2540–2546. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Paez-Ribes M, Allen E, Hudock J, et al:
Antiangiogenic therapy elicits malignant progression of tumors to
increased local invasion and distant metastasis. Cancer Cell.
15:220–231. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Norden AD, Drappatz J and Wen PY: Novel
anti-angiogenic therapies for malignant gliomas. Lancet Neurol.
7:1152–1160. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vredenburgh JJ, Desjardins A, Herndon JN,
et al: Bevacizumab plus irinotecan in recurrent glioblastoma
multiforme. J Clin Oncol. 25:4722–4729. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tuettenberg J, Friedel C and Vajkoczy P:
Angiogenesis in malignant glioma- a target for antitumor therapy?
Crit Rev Oncol Hematol. 59:181–193. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gan HK, Lappas M, Cao DX, Cvrljevdic A,
Scott AM and Johns TG: Targeting a unique EGFR epitope with
monoclonal antibody 806 activates NF-kappaB and initiates tumour
vascular normalization. J Cell Mol Med. 13:3993–4001. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jang FF, Wei W and De WM: Vascular
endothelial growth factor and basic fibroblast growth factor
expression positively correlates with angiogenesis and peritumoural
brain oedema in astrocytoma. J Ayub Med Coll Abbottabad.
20:105–109. 2008.
|
|
9
|
di Tomaso E, London N, Fuja D, et al:
PDGF-C induces maturation of blood vessels in a model of
glioblastoma and attenuates the response to anti-VEGF treatment.
PLoS One. 4:e51232009.PubMed/NCBI
|
|
10
|
Huse JT and Holland EC: Genetically
engineered mouse models of brain cancer and the promise of
preclinical testing. Brain Pathol. 19:132–143. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee LM, Seftor EA, Bonde G, Cornell RA and
Hendrix MJ: The fate of human malignant melanoma cells transplanted
into zebrafish embryos: assessment of migration and cell division
in the absence of tumor formation. Dev Dyn. 233:1560–1570. 2005.
View Article : Google Scholar
|
|
12
|
Stoletov K, Montel V, Lester RD, Gonias SL
and Klemke R: High-resolution imaging of the dynamic tumor cell
vascular interface in transparent zebrafish. Proc Natl Acad Sci
USA. 104:17406–17411. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jesuthasan S: Genetics and development.
Zebrafish in the spotlight. Science. 297:1484–1485. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stoletov K and Klemke R: Catch of the day:
zebrafish as a human cancer model. Oncogene. 27:4509–4520. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
White RM, Sessa A, Burke C, et al:
Transparent adult zebrafish as a tool for in vivo transplantation
analysis. Cell Stem Cell. 2:183–189. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cross LM, Cook MA, Lin S, Chen JN and
Rubinstein AL: Rapid analysis of angiogenesis drugs in a live
fluorescent zebrafish assay. Arterioscler Thromb Vasc Biol.
23:911–912. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Westerfield M: The Zebrafish Book. A Guide
for the Laboratory Use of Zebrafish (Danio rerio) Eugene, OR:
University of Oregon Press; 2007
|
|
18
|
Nicoli S, Ribatti D, Cotelli F and Presta
M: Mammalian tumor xenografts induce neovascularization in
zebrafish embryos. Cancer Res. 67:2927–2931. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nicoli S and Presta M: The zebrafish/tumor
xenograft angiogenesis assay. Nat Protoc. 2:2918–2923. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Serbedzija GN, Flynn E and Willett CE:
Zebrafish angiogenesis: a new model for drug screening.
Angiogenesis. 3:353–359. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thisse C and Thisse B: High-resolution in
situ hybridization to whole-mount zebrafish embryos. Nat Protoc.
3:59–69. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Adhikary S and Eilers M: Transcriptional
regulation and transformation by Myc proteins. Nat Rev Mol Cell
Biol. 6:635–645. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Spitsbergen JM, Tsai HW, Reddy A, et al:
Neoplasia in zebrafish (danio rerio) treated with
7,12-dimethylbenz[a]anthracene by two exposure routes at different
developmental stages. Toxicol Pathol. 28:705–715. 2000.PubMed/NCBI
|
|
24
|
Spitsbergen JM, Tsai HW, Reddy A, et al:
Neoplasia in zebrafish (Danio rerio) treated with
N-methyl-N′-nitro-N-nitrosoguanidine by three exposure routes at
different developmental stages. Toxicol Pathol. 28:716–725.
2000.PubMed/NCBI
|
|
25
|
Shepard JL, Amatruda JF, Stern HM, et al:
A zebrafish bmyb mutation causes genome instability and
increased cancer susceptibility. Proc Natl Acad Sci USA.
102:13194–13199. 2005.
|
|
26
|
Amatruda JF, Shepard JL, Stern HM and Zon
LI: Zebrafish as a cancer model system. Cancer Cell. 1:229–231.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mione MC and Trede NS: The zebrafish as a
model for cancer. Dis Model Mech. 3:517–523. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chi A, Norden AD and Wen PY: Inhibition of
angiogenesis and invasion in malignant gliomas. Expert Rev
Anticancer Ther. 7:1537–1560. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Leung DW, Cachianes G, Kuang WJ, Goeddel
DV and Ferrara N: Vascular endothelial growth factor is a secreted
angiogenic mitogen. Science. 246:1306–1309. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Plate KH, Breier G, Weich HA and Risau W:
Vascular endothelial growth factor is a potential tumour
angiogenesis factor in human gliomas in vivo. Nature. 359:845–848.
1992. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Roy H, Bhardwaj S and Yla-Herttuala S:
Biology of vascular endothelial growth factors. FEBS Lett.
580:2879–2887. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Neufeld G, Tessler S, Gitay-Goren H, Cohen
T and Levi BZ: Vascular endothelial growth factor and its
receptors. Prog Growth Factor Res. 5:89–97. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Neufeld G, Cohen T, Gengrinovitch S and
Poltorak Z: Vascular endothelial growth factor (VEGF) and its
receptors. FASEB J. 13:9–22. 1999.PubMed/NCBI
|
|
34
|
Habeck H, Odenthal J, Walderich B,
Maischein H and Schulte-Merker S: Analysis of a zebrafish VEGF
receptor mutant reveals specific disruption of angiogenesis. Curr
Biol. 12:1405–1412. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liang D, Xu X, Chin AJ, et al: Cloning and
characterization of vascular endothelial growth factor (VEGF) from
zebrafish, Danio rerio. Biochim Biophys Acta. 1397:14–20. 1998.
View Article : Google Scholar : PubMed/NCBI
|
